Last reviewed · How we verify
Bupivacaine 7 mg
At a glance
| Generic name | Bupivacaine 7 mg |
|---|---|
| Sponsor | Corporacion Parc Tauli |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery (NA)
- ERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy
- Ketamine, SGB and Combination Treatment for TBI (PHASE2)
- Phase 2B Upper Extremity Nerve Block Study (PHASE2)
- Postoperative Analgesic Efficacy of SPSIPB in Anterior Cervical Discectomy (NA)
- Observational Retrospective Study on Spinal Analgesia in Laparoscopic and Laparotomic Hysterectomy
- Ultrasound-Guided Thoracic Paravertebral Block With Steroid and Local Anesthetic for Acute Herpes Zoster: Effects on Pain Control and Prevention of Postherpetic Neuralgia (PHASE3)
- Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bupivacaine 7 mg CI brief — competitive landscape report
- Bupivacaine 7 mg updates RSS · CI watch RSS
- Corporacion Parc Tauli portfolio CI